| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/26/2013 | US8383344 Methods for quantification of microRNAs and small interfering RNAs |
| 02/26/2013 | US8383343 Methods of enriching for and identifying polymorphisms |
| 02/26/2013 | US8383342 Compositions, products, methods and systems to monitor water and other ecosystems |
| 02/26/2013 | US8383341 Method for non-invasive prenatal diagnosis |
| 02/26/2013 | US8383340 Method for purifying RNA on a preparative scale by means of HPLC |
| 02/26/2013 | US8383339 Liquid supramolecular nanostamping (LiSuNS) |
| 02/26/2013 | US8383338 Methods and systems for uniform enrichment of genomic regions |
| 02/26/2013 | US8383337 Methods using metal oxide particles for analyte detection |
| 02/26/2013 | US8383336 Antisense formulation |
| 02/26/2013 | US8383335 Method for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urine |
| 02/26/2013 | US8383334 Laminar library screen |
| 02/26/2013 | US8383333 HBV precore protein capable of forming particles |
| 02/26/2013 | US8383332 Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack |
| 02/26/2013 | US8383126 Bacterial pheromones and uses thereof |
| 02/26/2013 | US8383121 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof |
| 02/26/2013 | US8383115 Engineered scFv against bovine herpes virus type I |
| 02/26/2013 | US8383089 Use of IMP3 as a prognostic marker for cancer |
| 02/26/2013 | US8383062 Fluid processing device including size-changing barrier |
| 02/26/2013 | US8383036 Methods for neutralizing anthrax or anthrax spores |
| 02/26/2013 | US8382896 High throughput screening of crystallization materials |
| 02/26/2013 | CA2530785C 2'-terminator nucleotide-related methods and systems |
| 02/26/2013 | CA2493822C Methods and compositions for targeting secretory lysosomes |
| 02/26/2013 | CA2492068C Assays for assembly of ebola virus nucleocapsids |
| 02/26/2013 | CA2389644C A novel polypeptide hormone phosphatonin |
| 02/26/2013 | CA2358570C Protonated/acidified nucleic acids and methods of use |
| 02/26/2013 | CA2342115C Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use |
| 02/26/2013 | CA2327586C Fap.alpha.-specific antibody with improved producibility |
| 02/26/2013 | CA2324648C Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 02/26/2013 | CA2324381C An integrin heterodimer and a subunit thereof |
| 02/25/2013 | CA2750428A1 Systems and methods for enrichment and detection of particles |
| 02/21/2013 | WO2013026027A1 Compositions and methods for detecting allelic variants |
| 02/21/2013 | WO2013025972A1 Yeast-muc1 immunotherapeutic compositions and uses thereof |
| 02/21/2013 | WO2013025952A2 Methods and compositions for the treatment and diagnosis of breast cancer |
| 02/21/2013 | WO2013025773A2 Molecular markers associated with soybean root-knot nematode tolerance and methods of their use |
| 02/21/2013 | WO2013025589A1 Methods and compositions for diagnosis and prognosis in gastric cancer |
| 02/21/2013 | WO2013025519A1 High throughput sensitization detection devices and methods |
| 02/21/2013 | WO2013025400A1 Maize event hcem485, compositions and methods for detecting and use thereof |
| 02/21/2013 | WO2013025322A2 Marker-based prognostic risk score in liver cancer |
| 02/21/2013 | WO2013025261A2 Fluorogenic peptide probes and assays |
| 02/21/2013 | WO2013025099A1 Substrates for the detection of periopathogens of the oral cavity |
| 02/21/2013 | WO2013025095A1 New method and kit for prediction success of in vitro fertilization |
| 02/21/2013 | WO2013024918A1 Gene groups serving as observation indexes for cancer progression, and method for detecting the gene groups |
| 02/21/2013 | WO2013024865A1 Antitumor agent and therapeutic effect prediction method for patients with kras-mutated colorectal cancer |
| 02/21/2013 | WO2013024843A1 Ceramide derivative and golgi apparatus-labeling fluorescent probe using same |
| 02/21/2013 | WO2013024821A1 Suspension for parallel reaction, parallel reaction method, and screening method |
| 02/21/2013 | WO2013024817A1 Two-dimensional cell spreading device and cell spreading method using same |
| 02/21/2013 | WO2013024737A1 Method and kit for determining mushroom cultivation period |
| 02/21/2013 | WO2013024694A1 Solid-phase carrier for aminated oligonucleotide |
| 02/21/2013 | WO2013024421A1 Peptides and derivatives thereof for detection and control of salmonella |
| 02/21/2013 | WO2013024272A1 Gene markers for nasopharyngeal carcinoma |
| 02/21/2013 | WO2013024267A2 Novel compositions |
| 02/21/2013 | WO2013024264A1 Prognostic methodology |
| 02/21/2013 | WO2013024260A1 Barrier layer for glucose sensor |
| 02/21/2013 | WO2013024175A2 Diagnostic means and methods for type 2 diabetes |
| 02/21/2013 | WO2013024173A1 Computer implemented method for identifying regulatory regions or regulatory variations |
| 02/21/2013 | WO2013024118A1 Use of ccne2 as a stratification marker in the treatment of breast tumours with novel pan-cdk inhibitors |
| 02/21/2013 | WO2013024116A1 Use of mad2l2 as a stratification marker in the treatment of breast tumours with novel pan-cdk inhibitors |
| 02/21/2013 | WO2013024088A1 Endodontic imaging |
| 02/21/2013 | WO2013024072A1 Method for isolating nucleic acids |
| 02/21/2013 | WO2013024064A1 Composition and methods for rt-pcr comprising an anionic polymer |
| 02/21/2013 | WO2013024024A2 Quality assessment of induced pluripotent cells by referring to splicing signatures of pluripotency |
| 02/21/2013 | WO2013023770A1 Chromatin profiling assay |
| 02/21/2013 | WO2013023671A1 Microfluidic device and method for detecting analytes in a flow using electrochemical probes |
| 02/21/2013 | WO2013023623A1 Isolation, cloning and application of pms3, a gene for photoperiod-sensitive genic male-sterility in rice |
| 02/21/2013 | WO2013023243A1 Methods of controlling fructan synthesis in plants |
| 02/21/2013 | WO2013003376A3 Segregating target nucleic acid from mixed nucleic acid samples |
| 02/21/2013 | WO2013003216A4 Methods for determining response to neoadjuvant therapy and survival using microrna-10b |
| 02/21/2013 | WO2012177089A3 Interspecific and intraspecific chlorella strain microsatellite molecular marker |
| 02/21/2013 | WO2012174256A3 Dna methylation profiles in cancer |
| 02/21/2013 | WO2012173866A3 Methods of identifying an organism |
| 02/21/2013 | WO2012171949A3 Thromboemoblic disease markers |
| 02/21/2013 | WO2012162324A3 Method of diagnosing and treating an aspergillus species-associated condition |
| 02/21/2013 | WO2012162247A3 Monitoring systems for biomass processing systems |
| 02/21/2013 | WO2012150818A9 Method for predicting a risk of chronic myeloid leukemia, and diagnosis kit using same |
| 02/21/2013 | WO2012119243A9 Method and system for portable cell detection and analysis using microfluidic technology |
| 02/21/2013 | WO2012075331A3 Tissue implantable microbiosensor |
| 02/21/2013 | WO2011128820A8 Methods for the analysis of breast cancer disorders |
| 02/21/2013 | US20130047301 Molecular markers associated with soybean root-knot nematode tolerance and methods of their use |
| 02/21/2013 | US20130047300 Grain Filling of a Plant Through the Modulation of NADH-Glutamate Synthase |
| 02/21/2013 | US20130047275 Maize event HCEM485, compositions and methods for detecting and use thereof |
| 02/21/2013 | US20130047274 Cd4 t-cells involved in mammalian host response to epithelial cell infections and uses thereof |
| 02/21/2013 | US20130046134 Methods of generating engineered innervated tissue and uses thereof |
| 02/21/2013 | US20130046010 Sumo as a marker of cancer development and target for cancer therapy |
| 02/21/2013 | US20130046009 Rho kinase inhibitors for treatment of mastocytosis and acute myeloid leukemia |
| 02/21/2013 | US20130045947 Pla2activity as a marker for ovarian and other gynecologic cancers |
| 02/21/2013 | US20130045890 Test for male fertility |
| 02/21/2013 | US20130045886 Methods For Diagnosing Feline Coronavirus Infections |
| 02/21/2013 | US20130045885 Materials and methods for profiling micrornas |
| 02/21/2013 | US20130045882 Methods for assessing rna patterns |
| 02/21/2013 | US20130045876 Integrated microfluidic and solid state pyrosequencing systems |
| 02/21/2013 | US20130045874 Method of Diagnostic of Inflammatory Bowel Diseases |
| 02/21/2013 | US20130045501 Detection Device for Detecting Analytes in Liquid Specimen |
| 02/21/2013 | US20130045500 Cell evaluation method |
| 02/21/2013 | US20130045499 Compact Multifunctional Ligand to Enhance Colloidal Stability of Nanoparticles |
| 02/21/2013 | US20130045496 Automatic Fluid Sample Preparation Module, Automatic Analysis System and Method for Use Thereof |
| 02/21/2013 | US20130045484 Methods and kits for determining the toxicity of an agent |
| 02/21/2013 | US20130045483 Yeast cells expressing amyloid beta and uses therefor |
| 02/21/2013 | US20130045482 Bacteria and the uses thereof |
| 02/21/2013 | US20130045481 Process for the identification and traceability of plant components |
| 02/21/2013 | US20130045479 Methods for evaluating the stage of ovarian cancer or the survival rate of an ovarian cancer patient |